Endoscopic diagnosis and screening of Barrett's esophagus: Inconsistency of diagnostic criteria between Japan and Western countries

Abstract

Barrett's esophagus (BE) is an endoscopically identifiable premalignant condition for esophageal adenocarcinoma (EAC). To diagnose BE precisely, careful inspection of the anatomic landmarks, including the esophagogastric junction and the squamocolumnar junction is important. The distal end of the palisade vessels and the proximal end of the gastric folds are used as the landmark of the esophagogastric junction in endoscopic diagnosis, with the latter solely used internationally, except in some Asian countries, including Japan. In addition, the diagnostic criteria adopted internationally for BE are inconsistent, particularly between Japan and Western countries. Recently updated guidelines in Western countries have included length criteria, with a 1‐cm threshold of columnar epithelium by endoscopic observation and/or histologic confirmation of the presence of specialized intestinal metaplasia. Since BE is endoscopically diagnosed at any length without histologic assessment in Japan, the reported prevalence of short‐segment BE is very high in Japan compared with that in Western countries. Although guidelines on screening exist for BE, the current strategies based on the presence of chronic gastroesophageal reflux disease with multiple risk factors may miss the opportunity for early detection of EAC. Indeed, up to 40% of patients with EAC have no history of chronic gastroesophageal reflux disease. To discuss BE on the same footing worldwide, standardization of diagnostic criteria, screening indication, and establishment of effective techniques for detecting dysplastic lesions are eagerly awaited. Japanese guidelines for BE should be revised regarding the length criteria, including the minimum length and long‐segment BE, in line with the recently updated Western guidelines.

Role of linked color imaging for upper gastrointestinal disease: present and future

“…BE is a condition marked by an abnormality in the lining of the lower esophagus. 7 In some BE patients, precancerous changes in the tissue, known as dysplasia, can develop and are likely to develop into esophageal cancer.…”

Systematic Meta-Analysis of Computer-Aided Detection to Detect Early Esophageal Cancer using Hyperspectral Imaging

“…Esophageal squamous cell carcinoma (ESCC) is predominantly prevalent in developing nations, particularly in Africa and Asia, where squamous cells are more prevalent. In Japan, approximately 90% of esophageal cancer cases are attributed to ESCC [4]. The act of smoking is a prevalent risk factor associated with the development of ESSC, as documented in literature [5].…”